Specifically, in breast cancer, SF3B1 mutations induce a recurrent pattern of aberrant splicing, leading to activation of AKT and NF-κB, enhanced cell migration, and tumorigenesis in mammary epithelial and breast cancer cells (11). This evidence concerns the gene SF3B1 and breast cancer.